APO Research
Talk to an analyst

APO RESEARCH · REPORT

Voriconazole

Compare research editions
View pricing & licenses

Selected research

Industry Research

Voriconazole Industry Research Report 2026

26 December 2025139 pages

Choose your research edition.

Industry ResearchVoriconazole Industry Research Report 2026139 pages · $2,950 USDIndustry Growth & TrendsGlobal Voriconazole Industry Growth and Trends Forecast to 2032117 pages · $3,450 USDMarket StructureGlobal Voriconazole Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Voriconazole Market Outlook and Growth Opportunities 2026202 pages · $4,250 USDMarket Analysis & ForecastGlobal Voriconazole Market Analysis and Forecast 2026-2032201 pages · $4,950 USD

Market perspective

The global Voriconazole market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Voriconazole is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Voriconazole is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Voriconazole is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Voriconazole include Abbott, Takeda, Teva, Sandoz, 诺华, Mylan, Pfizer, GSK and Taj Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Voriconazole market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Voriconazole Market by Company

Abbott

Takeda

Teva

Sandoz

诺华

Mylan

Pfizer

GSK

Taj Pharmaceuticals

Squibb

Sichuan Beauty Sport Huakang Pharmaceutical

Macherey-Nagel GmbH

Jincheng HEALTH Pharmaceutical

GeneTech Pharm

Ebang Pharmaceutical

Daiichi Sankyo

Cilag AG

Aditya Pharma

Voriconazole Segment by Type

Injection Voriconazole

Voriconazole Freeze-dried Powder

Voriconazole Segment by Application

Hospital

Clinic

Other

Voriconazole Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Voriconazole market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Voriconazole and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Voriconazole.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Voriconazole manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Voriconazole by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Voriconazole in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Voriconazole Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Voriconazole Sales (K Units) of Manufacturers (2021-2026) Table 7. Global Voriconazole Sales Market Share by Manufacturers (2021-2026) Table 8. Global Voriconazole Revenue of Manufacturers (2021-2026) Table 9. Global Voriconazole Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Voriconazole Average Price (US$/Unit) of Manufacturers (2021-2026) Table 11. Global Voriconazole Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Voriconazole, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Voriconazole, Product Type & Application Table 14. Global Voriconazole Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Voriconazole by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Abbott Company Information Table 19. Abbott Business Overview Table 20. Abbott Voriconazole Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 21. Abbott Voriconazole Product Portfolio Table 22. Abbott Recent Developments Table 23. Takeda Company Information Table 24. Takeda Business Overview Table 25. Takeda Voriconazole Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 26. Takeda Voriconazole Product Portfolio Table 27. Takeda Recent Developments Table 28. Teva Company Information Table 29. Teva Business Overview Table 30. Teva Voriconazole Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 31. Teva Voriconazole Product Portfolio Table 32. Teva Recent Developments Table 33. Sandoz Company Information Table 34. Sandoz Business Overview Table 35. Sandoz Voriconazole Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 36. Sandoz Voriconazole Product Portfolio Table 37. Sandoz Recent Developments Table 38. 诺华 Company Information Table 39. 诺华 Business Overview Table 40. 诺华 Voriconazole Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 41. 诺华 Voriconazole Product Portfolio Table 42. 诺华 Recent Developments Table 43. Mylan Company Information Table 44. Mylan Business Overview Table 45. Mylan Voriconazole Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Mylan Voriconazole Product Portfolio Table 47. Mylan Recent Developments Table 48. Pfizer Company Information Table 49. Pfizer Business Overview Table 50. Pfizer Voriconazole Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 51. Pfizer Voriconazole Product Portfolio Table 52. Pfizer Recent Developments Table 53. GSK Company Information Table 54. GSK Business Overview Table 55. GSK Voriconazole Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 56. GSK Voriconazole Product Portfolio Table 57. GSK Recent Developments Table 58. Taj Pharmaceuticals Company Information Table 59. Taj Pharmaceuticals Business Overview Table 60. Taj Pharmaceuticals Voriconazole Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. Taj Pharmaceuticals Voriconazole Product Portfolio Table 62. Taj Pharmaceuticals Recent Developments Table 63. Squibb Company Information Table 64. Squibb Business Overview Table 65. Squibb Voriconazole Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Squibb Voriconazole Product Portfolio Table 67. Squibb Recent Developments Table 68. Sichuan Beauty Sport Huakang Pharmaceutical Company Information Table 69. Sichuan Beauty Sport Huakang Pharmaceutical Business Overview Table 70. Sichuan Beauty Sport Huakang Pharmaceutical Voriconazole Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Sichuan Beauty Sport Huakang Pharmaceutical Voriconazole Product Portfolio Table 72. Sichuan Beauty Sport Huakang Pharmaceutical Recent Developments Table 73. Macherey-Nagel GmbH Company Information Table 74. Macherey-Nagel GmbH Business Overview Table 75. Macherey-Nagel GmbH Voriconazole Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Macherey-Nagel GmbH Voriconazole Product Portfolio Table 77. Macherey-Nagel GmbH Recent Developments Table 78. Jincheng HEALTH Pharmaceutical Company Information Table 79. Jincheng HEALTH Pharmaceutical Business Overview Table 80. Jincheng HEALTH Pharmaceutical Voriconazole Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Jincheng HEALTH Pharmaceutical Voriconazole Product Portfolio Table 82. Jincheng HEALTH Pharmaceutical Recent Developments Table 83. GeneTech Pharm Company Information Table 84. GeneTech Pharm Business Overview Table 85. GeneTech Pharm Voriconazole Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. GeneTech Pharm Voriconazole Product Portfolio Table 87. GeneTech Pharm Recent Developments Table 88. Ebang Pharmaceutical Company Information Table 89. Ebang Pharmaceutical Business Overview Table 90. Ebang Pharmaceutical Voriconazole Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Ebang Pharmaceutical Voriconazole Product Portfolio Table 92. Ebang Pharmaceutical Recent Developments Table 93. Daiichi Sankyo Company Information Table 94. Daiichi Sankyo Business Overview Table 95. Daiichi Sankyo Voriconazole Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Daiichi Sankyo Voriconazole Product Portfolio Table 97. Daiichi Sankyo Recent Developments Table 98. Cilag AG Company Information Table 99. Cilag AG Business Overview Table 100. Cilag AG Voriconazole Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Cilag AG Voriconazole Product Portfolio Table 102. Cilag AG Recent Developments Table 103. Aditya Pharma Company Information Table 104. Aditya Pharma Business Overview Table 105. Aditya Pharma Voriconazole Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Aditya Pharma Voriconazole Product Portfolio Table 107. Aditya Pharma Recent Developments Table 108. Global Voriconazole Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 109. Global Voriconazole Sales by Region (2021-2026) & (K Units) Table 110. Global Voriconazole Sales Market Share by Region (2021-2026) Table 111. Global Voriconazole Sales by Region (2027-2032) & (K Units) Table 112. Global Voriconazole Sales Market Share by Region (2027-2032) Table 113. Global Voriconazole Revenue by Region (2021-2026) & (US$ Million) Table 114. Global Voriconazole Revenue Market Share by Region (2021-2026) Table 115. Global Voriconazole Revenue by Region (2027-2032) & (US$ Million) Table 116. Global Voriconazole Revenue Market Share by Region (2027-2032) Table 117. North America Voriconazole Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 118. North America Voriconazole Sales by Country (2021-2026) & (K Units) Table 119. North America Voriconazole Sales by Country (2027-2032) & (K Units) Table 120. North America Voriconazole Revenue by Country (2021-2026) & (US$ Million) Table 121. North America Voriconazole Revenue by Country (2027-2032) & (US$ Million) Table 122. Europe Voriconazole Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 123. Europe Voriconazole Sales by Country (2021-2026) & (K Units) Table 124. Europe Voriconazole Sales by Country (2027-2032) & (K Units) Table 125. Europe Voriconazole Revenue by Country (2021-2026) & (US$ Million) Table 126. Europe Voriconazole Revenue by Country (2027-2032) & (US$ Million) Table 127. Asia Pacific Voriconazole Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 128. Asia Pacific Voriconazole Sales by Country (2021-2026) & (K Units) Table 129. Asia Pacific Voriconazole Sales by Country (2027-2032) & (K Units) Table 130. Asia Pacific Voriconazole Revenue by Country (2021-2026) & (US$ Million) Table 131. Asia Pacific Voriconazole Revenue by Country (2027-2032) & (US$ Million) Table 132. South America Voriconazole Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 133. South America Voriconazole Sales by Country (2021-2026) & (K Units) Table 134. South America Voriconazole Sales by Country (2027-2032) & (K Units) Table 135. South America Voriconazole Revenue by Country (2021-2026) & (US$ Million) Table 136. South America Voriconazole Revenue by Country (2027-2032) & (US$ Million) Table 137. Middle East and Africa Voriconazole Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 138. Middle East and Africa Voriconazole Sales by Country (2021-2026) & (K Units) Table 139. Middle East and Africa Voriconazole Sales by Country (2027-2032) & (K Units) Table 140. Middle East and Africa Voriconazole Revenue by Country (2021-2026) & (US$ Million) Table 141. Middle East and Africa Voriconazole Revenue by Country (2027-2032) & (US$ Million) Table 142. Global Voriconazole Sales by Type (2021-2026) & (K Units) Table 143. Global Voriconazole Sales by Type (2027-2032) & (K Units) Table 144. Global Voriconazole Sales Market Share by Type (2021-2026) Table 145. Global Voriconazole Sales Market Share by Type (2027-2032) Table 146. Global Voriconazole Revenue by Type (2021-2026) & (US$ Million) Table 147. Global Voriconazole Revenue by Type (2027-2032) & (US$ Million) Table 148. Global Voriconazole Revenue Market Share by Type (2021-2026) Table 149. Global Voriconazole Revenue Market Share by Type (2027-2032) Table 150. Global Voriconazole Price by Type (2021-2026) & (US$/Unit) Table 151. Global Voriconazole Price by Type (2027-2032) & (US$/Unit) Table 152. Global Voriconazole Sales by Application (2021-2026) & (K Units) Table 153. Global Voriconazole Sales by Application (2027-2032) & (K Units) Table 154. Global Voriconazole Sales Market Share by Application (2021-2026) Table 155. Global Voriconazole Sales Market Share by Application (2027-2032) Table 156. Global Voriconazole Revenue by Application (2021-2026) & (US$ Million) Table 157. Global Voriconazole Revenue by Application (2027-2032) & (US$ Million) Table 158. Global Voriconazole Revenue Market Share by Application (2021-2026) Table 159. Global Voriconazole Revenue Market Share by Application (2027-2032) Table 160. Global Voriconazole Price by Application (2021-2026) & (US$/Unit) Table 161. Global Voriconazole Price by Application (2027-2032) & (US$/Unit) Table 162. Key Raw Materials Table 163. Raw Materials Key Suppliers Table 164. Voriconazole Distributors List Table 165. Voriconazole Customers List Table 166. Voriconazole Industry Trends Table 167. Voriconazole Industry Drivers Table 168. Voriconazole Industry Restraints Table 169. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Voriconazole Product Image Figure 5. Global Voriconazole Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Voriconazole Market Size (2021-2032) & (US$ Million) Figure 7. Global Voriconazole Sales (2021-2032) & (K Units) Figure 8. Global Voriconazole Average Price (US$/Unit) & (2021-2032) Figure 9. Injection Voriconazole Product Image Figure 10. Voriconazole Freeze-dried Powder Product Image Figure 11. Hospital Product Image Figure 12. Clinic Product Image Figure 13. Other Product Image Figure 14. Global Voriconazole Revenue Share by Manufacturers in 2025 Figure 15. Global Manufacturers of Voriconazole, Manufacturing Sites & Headquarters Figure 16. Global Top 5 and 10 Voriconazole Players Market Share by Revenue in 2025 Figure 17. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Voriconazole Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 19. Global Voriconazole Sales by Region in 2025 Figure 20. Global Voriconazole Revenue by Region in 2025 Figure 21. North America Voriconazole Market Size by Country in 2025 Figure 22. North America Voriconazole Sales Market Share by Country (2021-2032) Figure 23. North America Voriconazole Revenue Market Share by Country (2021-2032) Figure 24. United States Voriconazole Revenue Growth Rate (2021-2032) & (US$ Million) Figure 25. Canada Voriconazole Revenue Growth Rate (2021-2032) & (US$ Million) Figure 26. Mexico Voriconazole Revenue Growth Rate (2021-2032) & (US$ Million) Figure 27. Europe Voriconazole Market Size by Country in 2025 Figure 28. Europe Voriconazole Sales Market Share by Country (2021-2032) Figure 29. Europe Voriconazole Revenue Market Share by Country (2021-2032) Figure 30. Germany Voriconazole Revenue Growth Rate (2021-2032) & (US$ Million) Figure 31. France Voriconazole Revenue Growth Rate (2021-2032) & (US$ Million) Figure 32. U.K. Voriconazole Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. Italy Voriconazole Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. Russia Voriconazole Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Spain Voriconazole Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Netherlands Voriconazole Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Switzerland Voriconazole Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Sweden Voriconazole Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Poland Voriconazole Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Asia Pacific Voriconazole Market Size by Country in 2025 Figure 41. Asia Pacific Voriconazole Sales Market Share by Country (2021-2032) Figure 42. Asia Pacific Voriconazole Revenue Market Share by Country (2021-2032) Figure 43. China Voriconazole Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. Japan Voriconazole Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. South Korea Voriconazole Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. India Voriconazole Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. Australia Voriconazole Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. Taiwan Voriconazole Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Southeast Asia Voriconazole Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Southeast Asia Voriconazole Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. South America Voriconazole Market Size by Country in 2025 Figure 52. South America Voriconazole Sales Market Share by Country (2021-2032) Figure 53. South America Voriconazole Revenue Market Share by Country (2021-2032) Figure 54. Brazil Voriconazole Revenue Growth Rate (2021-2032) & (US$ Million) Figure 55. Argentina Voriconazole Revenue Growth Rate (2021-2032) & (US$ Million) Figure 56. Chile Voriconazole Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. Middle East and Africa Voriconazole Market Size by Country in 2025 Figure 58. Middle East and Africa Voriconazole Sales Market Share by Country (2021-2032) Figure 59. Middle East and Africa Voriconazole Revenue Market Share by Country (2021-2032) Figure 60. Egypt Voriconazole Revenue Growth Rate (2021-2032) & (US$ Million) Figure 61. South Africa Voriconazole Revenue Growth Rate (2021-2032) & (US$ Million) Figure 62. Israel Voriconazole Revenue Growth Rate (2021-2032) & (US$ Million) Figure 63. Türkiye Voriconazole Revenue Growth Rate (2021-2032) & (US$ Million) Figure 64. GCC Countries Voriconazole Revenue Growth Rate (2021-2032) & (US$ Million) Figure 65. Global Voriconazole Sales Market Share by Type (2021-2032) Figure 66. Global Voriconazole Revenue Market Share by Type (2021-2032) Figure 67. Global Voriconazole Price (US$/Unit) by Type (2021-2032) Figure 68. Global Voriconazole Sales Market Share by Application (2021-2032) Figure 69. Global Voriconazole Revenue Market Share by Application (2021-2032) Figure 70. Global Voriconazole Price (US$/Unit) by Application (2021-2032) Figure 71. Voriconazole Value Chain Figure 72. Voriconazole Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Voriconazole Industry Opportunities and Challenges

Scope & coverage.

Types
  • Injection Voriconazole
  • Voriconazole Freeze-dried Powder
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • Abbott
  • Takeda
  • Teva
  • Sandoz
  • 诺华
  • Mylan
  • Pfizer
  • GSK
  • Taj Pharmaceuticals
  • Squibb
  • Sichuan Beauty Sport Huakang Pharmaceutical
  • Macherey-Nagel GmbH
  • Jincheng HEALTH Pharmaceutical
  • GeneTech Pharm
  • Ebang Pharmaceutical
  • Daiichi Sankyo
  • Cilag AG
  • Aditya Pharma

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Voriconazole Market Size (2021-2032)
  4. 2.2.2 Global Voriconazole Sales (2021-2032)
  5. 2.2.3 Global Voriconazole Market Average Price (2021-2032)
  6. 2.3 Voriconazole by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Injection Voriconazole
  9. 2.3.3 Voriconazole Freeze-dried Powder
  10. 2.4 Voriconazole by Application
  11. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  12. 2.4.2 Hospital
  13. 2.4.3 Clinic
  14. 2.4.4 Other
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Voriconazole Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Voriconazole Sales (K Units) of Manufacturers (2021-2026)
  3. 3.3 Global Voriconazole Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Voriconazole Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Voriconazole Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Voriconazole, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Voriconazole, Product Type & Application
  8. 3.8 Global Manufacturers of Voriconazole, Established Date
  9. 3.9 Global Voriconazole Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Abbott
  2. 4.1.1 Abbott Company Information
  3. 4.1.2 Abbott Business Overview
  4. 4.1.3 Abbott Voriconazole Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Abbott Voriconazole Product Portfolio
  6. 4.1.5 Abbott Recent Developments
  7. 4.2 Takeda
  8. 4.2.1 Takeda Company Information
  9. 4.2.2 Takeda Business Overview
  10. 4.2.3 Takeda Voriconazole Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Takeda Voriconazole Product Portfolio
  12. 4.2.5 Takeda Recent Developments
  13. 4.3 Teva
  14. 4.3.1 Teva Company Information
  15. 4.3.2 Teva Business Overview
  16. 4.3.3 Teva Voriconazole Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Teva Voriconazole Product Portfolio
  18. 4.3.5 Teva Recent Developments
  19. 4.4 Sandoz
  20. 4.4.1 Sandoz Company Information
  21. 4.4.2 Sandoz Business Overview
  22. 4.4.3 Sandoz Voriconazole Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Sandoz Voriconazole Product Portfolio
  24. 4.4.5 Sandoz Recent Developments
  25. 4.5 诺华
  26. 4.5.1 诺华 Company Information
  27. 4.5.2 诺华 Business Overview
  28. 4.5.3 诺华 Voriconazole Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 诺华 Voriconazole Product Portfolio
  30. 4.5.5 诺华 Recent Developments
  31. 4.6 Mylan
  32. 4.6.1 Mylan Company Information
  33. 4.6.2 Mylan Business Overview
  34. 4.6.3 Mylan Voriconazole Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Mylan Voriconazole Product Portfolio
  36. 4.6.5 Mylan Recent Developments
  37. 4.7 Pfizer
  38. 4.7.1 Pfizer Company Information
  39. 4.7.2 Pfizer Business Overview
  40. 4.7.3 Pfizer Voriconazole Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Pfizer Voriconazole Product Portfolio
  42. 4.7.5 Pfizer Recent Developments
  43. 4.8 GSK
  44. 4.8.1 GSK Company Information
  45. 4.8.2 GSK Business Overview
  46. 4.8.3 GSK Voriconazole Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 GSK Voriconazole Product Portfolio
  48. 4.8.5 GSK Recent Developments
  49. 4.9 Taj Pharmaceuticals
  50. 4.9.1 Taj Pharmaceuticals Company Information
  51. 4.9.2 Taj Pharmaceuticals Business Overview
  52. 4.9.3 Taj Pharmaceuticals Voriconazole Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Taj Pharmaceuticals Voriconazole Product Portfolio
  54. 4.9.5 Taj Pharmaceuticals Recent Developments
  55. 4.10 Squibb
  56. 4.10.1 Squibb Company Information
  57. 4.10.2 Squibb Business Overview
  58. 4.10.3 Squibb Voriconazole Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Squibb Voriconazole Product Portfolio
  60. 4.10.5 Squibb Recent Developments
  61. 4.11 Sichuan Beauty Sport Huakang Pharmaceutical
  62. 4.11.1 Sichuan Beauty Sport Huakang Pharmaceutical Company Information
  63. 4.11.2 Sichuan Beauty Sport Huakang Pharmaceutical Business Overview
  64. 4.11.3 Sichuan Beauty Sport Huakang Pharmaceutical Voriconazole Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Sichuan Beauty Sport Huakang Pharmaceutical Voriconazole Product Portfolio
  66. 4.11.5 Sichuan Beauty Sport Huakang Pharmaceutical Recent Developments
  67. 4.12 Macherey-Nagel GmbH
  68. 4.12.1 Macherey-Nagel GmbH Company Information
  69. 4.12.2 Macherey-Nagel GmbH Business Overview
  70. 4.12.3 Macherey-Nagel GmbH Voriconazole Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 Macherey-Nagel GmbH Voriconazole Product Portfolio
  72. 4.12.5 Macherey-Nagel GmbH Recent Developments
  73. 4.13 Jincheng HEALTH Pharmaceutical
  74. 4.13.1 Jincheng HEALTH Pharmaceutical Company Information
  75. 4.13.2 Jincheng HEALTH Pharmaceutical Business Overview
  76. 4.13.3 Jincheng HEALTH Pharmaceutical Voriconazole Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 Jincheng HEALTH Pharmaceutical Voriconazole Product Portfolio
  78. 4.13.5 Jincheng HEALTH Pharmaceutical Recent Developments
  79. 4.14 GeneTech Pharm
  80. 4.14.1 GeneTech Pharm Company Information
  81. 4.14.2 GeneTech Pharm Business Overview
  82. 4.14.3 GeneTech Pharm Voriconazole Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 GeneTech Pharm Voriconazole Product Portfolio
  84. 4.14.5 GeneTech Pharm Recent Developments
  85. 4.15 Ebang Pharmaceutical
  86. 4.15.1 Ebang Pharmaceutical Company Information
  87. 4.15.2 Ebang Pharmaceutical Business Overview
  88. 4.15.3 Ebang Pharmaceutical Voriconazole Sales, Revenue and Gross Margin (2021-2026)
  89. 4.15.4 Ebang Pharmaceutical Voriconazole Product Portfolio
  90. 4.15.5 Ebang Pharmaceutical Recent Developments
  91. 4.16 Daiichi Sankyo
  92. 4.16.1 Daiichi Sankyo Company Information
  93. 4.16.2 Daiichi Sankyo Business Overview
  94. 4.16.3 Daiichi Sankyo Voriconazole Sales, Revenue and Gross Margin (2021-2026)
  95. 4.16.4 Daiichi Sankyo Voriconazole Product Portfolio
  96. 4.16.5 Daiichi Sankyo Recent Developments
  97. 4.17 Cilag AG
  98. 4.17.1 Cilag AG Company Information
  99. 4.17.2 Cilag AG Business Overview
  100. 4.17.3 Cilag AG Voriconazole Sales, Revenue and Gross Margin (2021-2026)
  101. 4.17.4 Cilag AG Voriconazole Product Portfolio
  102. 4.17.5 Cilag AG Recent Developments
  103. 4.18 Aditya Pharma
  104. 4.18.1 Aditya Pharma Company Information
  105. 4.18.2 Aditya Pharma Business Overview
  106. 4.18.3 Aditya Pharma Voriconazole Sales, Revenue and Gross Margin (2021-2026)
  107. 4.18.4 Aditya Pharma Voriconazole Product Portfolio
  108. 4.18.5 Aditya Pharma Recent Developments
5 Global Voriconazole Market Scenario by Region
  1. 5.1 Global Voriconazole Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Voriconazole Sales by Region: 2021-2032
  3. 5.2.1 Global Voriconazole Sales by Region: 2021-2026
  4. 5.2.2 Global Voriconazole Sales by Region: 2027-2032
  5. 5.3 Global Voriconazole Revenue by Region: 2021-2032
  6. 5.3.1 Global Voriconazole Revenue by Region: 2021-2026
  7. 5.3.2 Global Voriconazole Revenue by Region: 2027-2032
  8. 5.4 North America Voriconazole Market Facts & Figures by Country
  9. 5.4.1 North America Voriconazole Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Voriconazole Sales by Country (2021-2032)
  11. 5.4.3 North America Voriconazole Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Voriconazole Market Facts & Figures by Country
  16. 5.5.1 Europe Voriconazole Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Voriconazole Sales by Country (2021-2032)
  18. 5.5.3 Europe Voriconazole Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Voriconazole Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Voriconazole Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Voriconazole Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Voriconazole Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Voriconazole Market Facts & Figures by Country
  41. 5.7.1 South America Voriconazole Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Voriconazole Sales by Country (2021-2032)
  43. 5.7.3 South America Voriconazole Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.8 Middle East and Africa Voriconazole Market Facts & Figures by Country
  48. 5.8.1 Middle East and Africa Voriconazole Market Size by Country: 2021 VS 2025 VS 2032
  49. 5.8.2 Middle East and Africa Voriconazole Sales by Country (2021-2032)
  50. 5.8.3 Middle East and Africa Voriconazole Revenue by Country (2021-2032)
  51. 5.8.4 Egypt
  52. 5.8.5 South Africa
  53. 5.8.6 Israel
  54. 5.8.7 Türkiye
  55. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Voriconazole Sales by Type (2021-2032)
  2. 6.1.1 Global Voriconazole Sales by Type (2021-2032) & (K Units)
  3. 6.1.2 Global Voriconazole Sales Market Share by Type (2021-2032)
  4. 6.2 Global Voriconazole Revenue by Type (2021-2032)
  5. 6.2.1 Global Voriconazole Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Voriconazole Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Voriconazole Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Voriconazole Sales by Application (2021-2032)
  2. 7.1.1 Global Voriconazole Sales by Application (2021-2032) & (K Units)
  3. 7.1.2 Global Voriconazole Sales Market Share by Application (2021-2032)
  4. 7.2 Global Voriconazole Revenue by Application (2021-2032)
  5. 7.2.1 Global Voriconazole Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Voriconazole Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Voriconazole Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Voriconazole Value Chain Analysis
  2. 8.1.1 Voriconazole Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Voriconazole Production Mode & Process
  5. 8.2 Voriconazole Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Voriconazole Distributors
  8. 8.2.3 Voriconazole Customers
9 Global Voriconazole Analyzing Market Dynamics
  1. 9.1 Voriconazole Industry Trends
  2. 9.2 Voriconazole Industry Drivers
  3. 9.3 Voriconazole Industry Opportunities and Challenges
  4. 9.4 Voriconazole Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst